Role of cholecystokinetic agents in 99mTc-IDA cholescintigraphy

Leonard M. Freeman, Leroy A. Sugarman, Heidi S. Weissmann

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Cholecystokinin (CCK) and its C-terminal octapeptide analog. Sincalide, have been utilized in two separate roles for the evaluation of gallbladder disease. These are: (1) prior to cholescintigraphy to evacuate the gallbladder and optimize subsequent filling with radiotracers, and (2) to study contractile function of visualizing gallbladders on cholecystography and cholescintigraphy. As a preparation for 99mTc-IDA studies, it clearly facilitates earlier gall-bladder filling in patients with chronic cholecystitis, thereby ruling out complete cystic duct obstruction. The problem lies in the fact that the use of CCK as a premedication markedly decreases the sensitivity of the study to detect chronic cholecystitis, since the findings become indistinguishable from patients with normal gallbladders. For this reason, the authors prefer to obtain delayed images, since chronic cholecystitis is frequently associated with gallbladder filling beyond the first hour. The role of CCK in detecting abnormal gallbladder function in the normally visualizing gallbladder also is controversial. Other studies as well as the authors' experience suggest that as much as one-fourth of positive cases may be associated with normal gallbladders at surgery and often even on microscopic examination. However, most importantly, the great majority of these patients are relieved of their symptoms following surgery. It appears reasonable that CCK or Sincalide cholescystography or cholescintigraphy may be detecting functional abnormalities before anatomic changes occur and can, therefore, serve as a useful examination in selecting symptomatic patients who may benefit from cholecystectomy.

Original languageEnglish (US)
Pages (from-to)186-193
Number of pages8
JournalSeminars in Nuclear Medicine
Volume11
Issue number3
DOIs
StatePublished - 1981

Fingerprint

Gallbladder
Cholecystokinin
Cholecystitis
Sincalide
Cholecystography
Gallbladder Diseases
Cystic Duct
Premedication
Cholecystectomy
Urinary Bladder

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Role of cholecystokinetic agents in 99mTc-IDA cholescintigraphy. / Freeman, Leonard M.; Sugarman, Leroy A.; Weissmann, Heidi S.

In: Seminars in Nuclear Medicine, Vol. 11, No. 3, 1981, p. 186-193.

Research output: Contribution to journalArticle

Freeman, Leonard M. ; Sugarman, Leroy A. ; Weissmann, Heidi S. / Role of cholecystokinetic agents in 99mTc-IDA cholescintigraphy. In: Seminars in Nuclear Medicine. 1981 ; Vol. 11, No. 3. pp. 186-193.
@article{37f0b502dec044978de5859d98aa1cce,
title = "Role of cholecystokinetic agents in 99mTc-IDA cholescintigraphy",
abstract = "Cholecystokinin (CCK) and its C-terminal octapeptide analog. Sincalide, have been utilized in two separate roles for the evaluation of gallbladder disease. These are: (1) prior to cholescintigraphy to evacuate the gallbladder and optimize subsequent filling with radiotracers, and (2) to study contractile function of visualizing gallbladders on cholecystography and cholescintigraphy. As a preparation for 99mTc-IDA studies, it clearly facilitates earlier gall-bladder filling in patients with chronic cholecystitis, thereby ruling out complete cystic duct obstruction. The problem lies in the fact that the use of CCK as a premedication markedly decreases the sensitivity of the study to detect chronic cholecystitis, since the findings become indistinguishable from patients with normal gallbladders. For this reason, the authors prefer to obtain delayed images, since chronic cholecystitis is frequently associated with gallbladder filling beyond the first hour. The role of CCK in detecting abnormal gallbladder function in the normally visualizing gallbladder also is controversial. Other studies as well as the authors' experience suggest that as much as one-fourth of positive cases may be associated with normal gallbladders at surgery and often even on microscopic examination. However, most importantly, the great majority of these patients are relieved of their symptoms following surgery. It appears reasonable that CCK or Sincalide cholescystography or cholescintigraphy may be detecting functional abnormalities before anatomic changes occur and can, therefore, serve as a useful examination in selecting symptomatic patients who may benefit from cholecystectomy.",
author = "Freeman, {Leonard M.} and Sugarman, {Leroy A.} and Weissmann, {Heidi S.}",
year = "1981",
doi = "10.1016/S0001-2998(81)80003-7",
language = "English (US)",
volume = "11",
pages = "186--193",
journal = "Seminars in Nuclear Medicine",
issn = "0001-2998",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Role of cholecystokinetic agents in 99mTc-IDA cholescintigraphy

AU - Freeman, Leonard M.

AU - Sugarman, Leroy A.

AU - Weissmann, Heidi S.

PY - 1981

Y1 - 1981

N2 - Cholecystokinin (CCK) and its C-terminal octapeptide analog. Sincalide, have been utilized in two separate roles for the evaluation of gallbladder disease. These are: (1) prior to cholescintigraphy to evacuate the gallbladder and optimize subsequent filling with radiotracers, and (2) to study contractile function of visualizing gallbladders on cholecystography and cholescintigraphy. As a preparation for 99mTc-IDA studies, it clearly facilitates earlier gall-bladder filling in patients with chronic cholecystitis, thereby ruling out complete cystic duct obstruction. The problem lies in the fact that the use of CCK as a premedication markedly decreases the sensitivity of the study to detect chronic cholecystitis, since the findings become indistinguishable from patients with normal gallbladders. For this reason, the authors prefer to obtain delayed images, since chronic cholecystitis is frequently associated with gallbladder filling beyond the first hour. The role of CCK in detecting abnormal gallbladder function in the normally visualizing gallbladder also is controversial. Other studies as well as the authors' experience suggest that as much as one-fourth of positive cases may be associated with normal gallbladders at surgery and often even on microscopic examination. However, most importantly, the great majority of these patients are relieved of their symptoms following surgery. It appears reasonable that CCK or Sincalide cholescystography or cholescintigraphy may be detecting functional abnormalities before anatomic changes occur and can, therefore, serve as a useful examination in selecting symptomatic patients who may benefit from cholecystectomy.

AB - Cholecystokinin (CCK) and its C-terminal octapeptide analog. Sincalide, have been utilized in two separate roles for the evaluation of gallbladder disease. These are: (1) prior to cholescintigraphy to evacuate the gallbladder and optimize subsequent filling with radiotracers, and (2) to study contractile function of visualizing gallbladders on cholecystography and cholescintigraphy. As a preparation for 99mTc-IDA studies, it clearly facilitates earlier gall-bladder filling in patients with chronic cholecystitis, thereby ruling out complete cystic duct obstruction. The problem lies in the fact that the use of CCK as a premedication markedly decreases the sensitivity of the study to detect chronic cholecystitis, since the findings become indistinguishable from patients with normal gallbladders. For this reason, the authors prefer to obtain delayed images, since chronic cholecystitis is frequently associated with gallbladder filling beyond the first hour. The role of CCK in detecting abnormal gallbladder function in the normally visualizing gallbladder also is controversial. Other studies as well as the authors' experience suggest that as much as one-fourth of positive cases may be associated with normal gallbladders at surgery and often even on microscopic examination. However, most importantly, the great majority of these patients are relieved of their symptoms following surgery. It appears reasonable that CCK or Sincalide cholescystography or cholescintigraphy may be detecting functional abnormalities before anatomic changes occur and can, therefore, serve as a useful examination in selecting symptomatic patients who may benefit from cholecystectomy.

UR - http://www.scopus.com/inward/record.url?scp=0019590342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019590342&partnerID=8YFLogxK

U2 - 10.1016/S0001-2998(81)80003-7

DO - 10.1016/S0001-2998(81)80003-7

M3 - Article

VL - 11

SP - 186

EP - 193

JO - Seminars in Nuclear Medicine

JF - Seminars in Nuclear Medicine

SN - 0001-2998

IS - 3

ER -